UNSPSC 51111872: Zanoterone

This classification denotes an anti-androgen with the molecular formula C23H32N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XQ5V1W49JG, chemically known as 1-(methylsulfonyl)-1h-5alpha,17alpha-pregn-20-yno(3,2-c)pyrazol-17-ol but generally known as zanoterone, which bears US NIH Compound Identifier 60180. European Medicines Agency schedules Zanoterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00139MIG.

UNSPSC 51111872 Zanoterone, a Commodity code, covers pharmaceutical active ingredients and finished-dose medications supplied through state and local cooperative purchasing alliances and direct agency procurement. Recent solicitations show state and local governments buying generic multi-source pharmaceuticals and over-the-counter products through cooperative vehicles, with vendors supplying through authorized pharmaceutical wholesalers and managing National Drug Code (NDC) compliance, cGMP certification, and Drug Supply Chain Security Act (DSCSA) compliance. State procurement offices and multistate purchasing consortia are the primary issuing bodies; repeat purchasing through cooperative agreements drives sustained activity under this code rather than episodic individual agency solicitations.

The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued a Request for Proposal on January 20, 2026 (S1070000015802) to establish multiple contracts for generic pharmaceuticals and OTC products effective July 1, 2026, with proposals due March 26, 2026. Vendors must supply through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and maintain contractual relationships with at least two of them with chargeback systems operational. Evaluation emphasizes price competitiveness (75 percent weight), with smaller components for fixed pricing, administrative-fee compliance, EDI capability, and format adherence. The contract runs two years for new vendors with optional extensions; MMCAP reserves multi-award rights based on therapeutic need and member-specific requirements. Participants must carry $5 million commercial general liability coverage and maintain product shelf life of at least six months from manufacture with one-year minimum expiration dating.